American Regent Sodium Chloride Recall: Particulate Contamination

Visible particles found floating in vials has led to a recall of 21 lots of concentrated sodium chloride injections made by American Regent. 

The sodium chloride recall was announced on March 15 by the FDA after the manufacturer discovered the problem and pulled the injections.

American Regent, Inc. says it has identified the source of the particulates and has made changes to correct the issue, however the company did not identify what the particles were made of, or how they got into the sodium chloride injections.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

According to the company, the particulates could disrupt blood flow in the lung, and cause localized inflammation and granuloma formation. There have been no reports of illness or injury reported in connection to the contaminated sodium chloride injections.

The recall affects 16 lots of concentrated sodium chloride injection, USP 23.4% in 30 mL single dose vials with NDC# 0517-2930-25. Also being recalled are 5 lots of concentrated sodium chloride injection, USP 23.4% in 100 mL pharmacy bulk packages with NDC# 0517-2900-25. A complete list of lot numbers, expiration dates and distribution dates is available on the recall notice .

Concentrated sodium chloride injections are used to treat patients that have problems taking in or excreting sodium electrolytes.

This is the third recall of American Regent injectable drugs this year due to particulate contamination. In early January, the company issued an Acetadote recall affecting six lots. In early February one lot of sodium thiosulfate was recalled after flakes of glass were found in some vials.

American Regent says it will credit accounts for all customers affected by the recall. Healthcare providers or patients with questions should contact American Regent’s Professional Services Department at 1-877-788-3232. Anyone experiencing an adverse reaction is asked to report the problem to American Regent Inc. via e-mail at PV@luitpold.com. Adverse reactions should also be reported to the FDA’s MedWatch program online at www.fda.gov/medwatch/report.htm.

Image Credit: |

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Johnson & Johnson Faces Medical Monitoring Lawsuit Over Future Baby Powder Cancer Risks
Johnson & Johnson Faces Medical Monitoring Lawsuit Over Future Baby Powder Cancer Risks (Posted today)

Women who used Johnson's Baby Powder around their genitals for feminine hygiene purposes now live in fear of developing ovarian cancer, according to the class action lawsuit seeking medical monitoring for future diagnoses

More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing
More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing (Posted yesterday)

A bundled complaint of about 9,600 Suboxone lawsuits were filed in federal court on Friday, ahead of the two-year anniversary of the FDA requiring tooth decay label warnings on the opioid treatment film strips, which is also a deadline for filing a civil complaint in many states.